Systemic Inflammation Across Metabolic Obesity Phenotypes: A Cross-Sectional Study of Korean Adults Using High-Sensitivity C-Reactive Protein as a Biomarker

Int J Mol Sci. 2024 Oct 27;25(21):11540. doi: 10.3390/ijms252111540.

Abstract

Chronic systemic inflammation is a hallmark of obesity. This cross-sectional study aimed to investigate the association between metabolic obesity phenotypes and inflammatory markers in Korean adults (N = 21,112; mean age: 50.9 ± 16.6). Metabolic obesity phenotypes were categorized into metabolically healthy non-obesity (MHNO), metabolically unhealthy non-obesity (MUNO), metabolically healthy obesity (MHO), and metabolically unhealthy obesity (MUO) based on body mass index and the presence of any metabolic abnormalities. High-sensitivity C-reactive protein (hs-CRP) levels were measured. Multiple linear regression was used to determine the association between obesity phenotypes and hs-CRP levels. In the male sample, compared to the MHNO type, the MUNO, MHO, and MUO types were associated with a 22.3% (95% confidence interval; CI: 14.7-30.3%), 15.8% (95% CI: 2.6-30.7%), and 12.5% (95% CI: 3.0-22.9%) increase in the hs-CRP levels, respectively. The association between metabolic obesity types and hs-CRP levels was stronger among the female sample; compared to the MHNO type, the MUNO, MHO, and MUO types were associated with a 30.2% (95% CI: 22.8-38.2%), 16.0% (95% CI: 6.5-26.4%), and 22.8% (95% CI: 13.6-32.8%) increase in the hs-CRP levels, respectively. Our findings indicate a varying profile of systemic inflammation across different metabolic obesity phenotypes.

Keywords: adiposity; body weight; metabolic syndrome; oxidative stress.

MeSH terms

  • Adult
  • Aged
  • Biomarkers* / blood
  • Body Mass Index*
  • C-Reactive Protein* / analysis
  • C-Reactive Protein* / metabolism
  • Cross-Sectional Studies
  • Female
  • Humans
  • Inflammation* / blood
  • Inflammation* / metabolism
  • Male
  • Middle Aged
  • Obesity* / blood
  • Obesity* / metabolism
  • Phenotype*
  • Republic of Korea / epidemiology

Substances

  • C-Reactive Protein
  • Biomarkers

Grants and funding

This research received no external funding.